‘Possible link’ between Johnson & Johnson vaccine and blood clots, European regulator finds

The European drugs regulator has found a “possible link” between the Johnson & Johnson vaccine and very rare blood clots detected in some recipients of the jab.

A warning over the clotting, which is combined with low blood platelet counts in the cases of concern, should be listed as a rare side effect for the vaccine, the safety committee for the European Medicines Agency said.

However, it insisted that the overall benefit of the jab in providing protection against Covid-19 outweighs any associated risk.

Based on the currently available evidence, specific factors that might heighten an individual’s chances of developing the blood clots have not been confirmed.

More to follow


READ  Wood-based flexible tech creates electricity from body heat - The Indian Express


Please enter your comment!
Please enter your name here